A therapy that retrains the body's immune system to fight cancer has created much excitement after more than 90% of terminally ill patients went into remission. But closer analysis of the trial reveals something more. Prof Dato Dr Fuad Ismail joins Dr George Lee to give us a perspective into the future of cancer treatment.

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  health and living,  cancer immunotherapy,  cancer management,  terminal cancer,  blood,  immunology,  non-hodgkin lymphoma,  acute lymphoblastic leukemia,  leukemia,  lymphoma,  Health